Resources Contact Us Home
Solid oral dosage form containing an enhancer

Image Number 17 for United States Patent #8119159.

The invention relates to a pharmaceutical composition and oral dosage forms comprising a bisphosphonate in combination with an enhancer to promote absorption of the bisphosphonate at the GIT cell lining. The enhancer is a medium chain fatty acid or a medium chain fatty acid derivative having a carbon chain length of from 6 to 20 carbon atoms. Preferably, the solid oral dosage form is a controlled release dosage form such as a delayed release dosage form.

  Recently Added Patents
Prioritizing application data for transmission in a wireless user device
Method and system for distributing load by redirecting traffic
Error correct coding device, error correct coding method, and error correct coding program
Strongly bound carbon nanotube arrays directly grown on substrates and methods for production thereof
Method for isomerisation of hop alpha-acids using heterogeneous alkaline earth metal based catalysts
Method and apparatus for sensing an input object relative to a sensing region of an ultrasound sensor device
Methods for increasing efficacy of FOLR1 cancer therapy
  Randomly Featured Patents
Combined vacuum cleaner hose and rack
Article for fixing panel
Indoline compound and process for producing the same
Tricyclic nitrogen containing compounds as antibacterial agents
System and method for latency reduction for automatic speech recognition using partial multi-pass results
Acidic hair care preparations
Measuring arrangement having a plurality of measuring points connected to one another by means of a cable
Inert gas environmental control system for a hyperbaric chamber and a method for doing same
Method of handling system calls to an operating system of a computer by system service routines stored as firmware
Olefin hydroformylation